Hale, MD, Martin E., United States

• Vol 11, No 5 (2015): September/October - Articles
  Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain
  Abstract
• Vol 11, No 6 (2015): November/December - Articles
  Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain
  Abstract
• Vol 12, No 2 (2016): March/April - Articles
  Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential
  Abstract
• Vol 8, No 5 (2012): September/October - Articles
  Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: Pooled analysis of 13 studies
  Abstract